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Abstract: The unique combination of mechanical, optical and electrical properties offered by carbon
nanotubes has fostered research for their use in many kinds of applications, including the biomedical
ﬁeld. However, due to persisting outstanding questions regarding their potential toxicity when
considered as free particles, the research is now focusing on their immobilization on substrates for
interface tuning or as biosensors, as load in nanocomposite materials where they improve both
mechanical and electrical properties or even for direct use as scaffolds for tissue engineering. After a
brief introduction to carbon nanotubes in general and their proposed applications in the biomedical
ﬁeld, this review will focus on nanocomposite materials with hydrogel-based matrices and especially
their potential future use for diagnostics, tissue engineering or targeted drug delivery. The toxicity
issue will also be brieﬂy described in order to justify the safe(r)-by-design approach offered by carbon
nanotubes-based hydrogels.
Keywords: nanocomposites; hydrogels; diagnostic; drug delivery; tissue engineering
1. Introduction
Biomaterials are a key element of medical devices. Due to their speciﬁc properties related to the
nanoscale [1], nanoparticles have progressively been introduced in biomaterials. The large ratio of
surface atoms, compared to those in the bulk, increases their chemical reactivity and signiﬁcantly
modiﬁes their physico-chemical properties in general (modiﬁed photocatalytic activity or even
transparency for example in the case of nano TiO2, faster dissolution in most cases, modiﬁed electronic
properties, etc.), which can be very useful in biomedical applications. If they are designed to be released,
their size also allows a much faster distribution in the body. Among nanoparticles in general, carbon
nanomaterials combine interesting properties such as a very high chemical resistance (no dissolution
even in aggressive environments), excellent mechanical properties and a very light weight. The most
used carbon nanomaterials include nanodiamonds (ND), carbon nanotubes (CNT) and graphene and
its related materials (GRM: few-layer graphene (FLG), graphene oxide (GO), reduced graphene oxide
(rGO)) [2]. Carbon nanomaterials also exhibit a wide range of morphologies from 0D (nanodiamonds)
to nanowires (1D: carbon nanotubes) and nanosheets or nanoplatelets (2D: GRM). Among carbon
nanomaterials, CNT exhibit a unique combination of mechanical, electrical and optical properties with
also the possibility to ﬁll them with different compounds including drugs [3] and are thus among
the most promising nanomaterials for biomedical applications. Because of potential toxicity issues
for nanomaterials in general when used as free particles, the current strategy is to favour their use in
nanocomposite materials (Figure 1), as load in a biocompatible matrix (safe(r) by design approach).
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In this review, we have focused especially on hydrogel matrices, which are currently intensively
investigated for biomedical applications.
?
Figure 1. Scheme of the topics addressed in this review: Carbon nanotubes (CNTs) are good materials
for various biomedical applications but they raise several question about toxicity. Their utilization as
component in nanocomposites like CNTs-based hydrogels could limit those concerns.
2. Carbon Nanotubes (CNT) for Biomedical Applications
Carbon nanotubes are an allotropic form of carbon identiﬁed in 1991 by Iijima and since widely
studied and used for a wide range of applications such as materials reinforcement, electrode materials
and/or components for nanoelectronics (biosensors) or even (which could be remotely activated
in some cases) drug carriers in biomedicine. They can be synthesized by different methods which
will not be described in detail here but include the historical electric-arc discharge, laser ablation
and the wide family of catalytic chemical vapour deposition (CCVD) techniques [4]. CNT can be
described as a rolled-up graphene layer, sometimes closed at the end by fullerene caps. The number
of concentric walls composing a CNT (if more than one) is an essential parameter that determines
many properties. Single-wall CNT (SWCNT) have a small dimeter, most often between 1 and 2 nm,
whereas multi-walled CNT (MWCNT) outer dimeter can reach ca. 100 nm. Increasing the number
of layers in MWCNT inevitably also increases the number of defects and thus makes them easier to
modify and to functionalise, most of the time at the cost of a degradation of their physical properties.
Double-wall CNT (DWCNT) are at the interface between SWCNT and MWCNT: they exhibit many
characteristics of SWCNT, such as a very narrow diameter and excellent mechanical properties but
can, as MWCNT, be covalently functionalised without degrading much their electrical conductivity
thanks to the presence of a second outer wall. Indeed, the question of role played by the surface
chemistry of nanoparticles in general is a crucial one and CNT are no exception to the rule. It is well
known that the intrinsic chemical composition and crystal structure of a nanoparticle will lead to
different surface properties such as charge, hydrophobicity or hydrophilicity, possible dissolution,
(photo)catalytic activity and so forth [5]. This will drive the interactions of the nanoparticle with
its environment and especially the adsorption of proteins (corona). On the other hand, it has also
been demonstrated that the decoration of the surface of any nanoparticle can modify their surface
properties and ﬁnally lead to a rather different biological behaviour, with a marked impact on their
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biodistribution [6]. Similar results have also been described for CNT, which will be discussed in detail
in the ﬁnal section. In many cases, CNT are covalently functionalized by oxidation (HNO3 alone
or mixed with H2SO4), leading to the grafting of oxygen-containing functional groups (hydroxyl,
carboxylic acid) at the surface of the outer wall, as well as to the opening of the CNT [7]. However,
in many other cases, the functionalization is non-covalent, by simple adsorption of different kinds of
molecules including polymers, DNA as well as carbohydrates and derivatives [8–10].
Application of CNT in the biomedical ﬁeld requires a few challenges to be met. The ﬁrst one is
related to safety and implies to use very high purity CNT in order to limit potential release of toxic
ions during operation in any biological environment. This is a real challenge because high purity
CNT samples usually cannot be prepared in very large scale and a compromise between quality and
quantity often has to be made. The other main challenges are more related to formulation issues,
not only in the biomedical ﬁeld. Being able to achieve good dispersions of CNT in solvents and
especially in water is one of the major ones. The strong hydrophobicity of CNT make them not only
difﬁcult to separate/individualize in a solvent but also to stabilize the suspension. This can be achieved
through functionalization (covalently by chemical oxidation for example or most often non-covalently
by addition of a dispersing agent or a surfactant), as has already been discussed. Another strategy,
because CNT are always difﬁcult to disperse when starting from a dry powder, is to limit or avoid
drying steps during their processing. Another challenge is the typical viscosity increase related to
the proper dispersion of CNT in a ﬂuid, even at low concentration [11], which can make difﬁcult to
prepare nanocomposite materials with a high volume fraction of well-dispersed CNT.
Depending on their electronic structure, SWCNT can behave either as semiconductors or as metals.
Within a random SWCNT population, there is a statistical distribution of 2/3 of semiconducting ones
and 1/3 metallic of metallic ones [4]. When the number of concentric walls increases, the inter-wall
interactions lead to a progressive increase in the population of metallic MWCNT. In terms of mechanical
performances, they can exhibit a large surface area up to 1000 m2 g−1 in the case of DWCNT [12], a very
high aspect ratio and low density [13] as well as an excellent mechanical resistance (better than steel
along their axis) and an excellent flexibility when the number of walls is low (this is especially true for
CCVD CNT). As described by Mohajeri et al. [14], CNT are more and more used for biomedical purposes
due to their rather good biocompatibility, either for diagnostics or for the treatment of various diseases.
2.1. CNT Use for Diagnostic
As early diagnostic is a key point for an efﬁcient treatment, the improvement of detection methods
is especially relevant. In vitro analysis of biomarkers is already possible with good accuracy thanks
to the detection immune complexes but can be time consuming and also require large amounts of
biological samples when using classical dosage strategies. Due to their electronic properties, several
teams have considered using CNTs as the key element of electrochemical sensors and different kind of
label-free CNT-based biosensors were developed.
CNT can also act as contrast agents in different bio imaging methods [15]. Functionalised and
conjugated with various biomarkers they can point out the presence and localisation of targeted cells
with a rather good spatial resolution.
2.1.1. Biosensors Based on CNT
In the biosensors ﬁeld, CNT have been proposed as sensing element to detect and monitor
several diseases, especially diabetes but also bacterial infection. For instance, Punbusayakul et al. used
electrochemical monitoring of immune complexes for salmonella detection, reducing thus the detection
time and facilitating the sample preparation compared to existing methods [16]. An immunosensor for
adiponectin—an obesity biomarker—was also obtained by grafting oriented antibodies on DWCNT
surface in order to immobilise them. A second antibody, conjugated with horse radish peroxidase
(HRP)-streptavidin binds to adiponectin and reacts with the substrate during cyclic voltammetry
monitoring, allowing thereby fast detection and quantiﬁcation [17].
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Generally speaking, the presence of CNT at the surface of the electrodes allows faster electron
transfer and improves the sensitivity for electrochemical detection [18]. Field-Effect Transistor
(FET)-based sensors have been reported to have excellent sensitivity [19,20], sometimes as low as
attomole according to Ramnani et al. [21]. Recently resistive sensors and more precisely differential
resistive pulse sensors (RPS) based on MWCNT, proved their great utility reaching the single molecule
detection threshold [22].
Another recent approach demonstrated the interest of porosity as a way to immobilize molecules
on biosensor electrode. Zhang et al. described a non-enzymatic glucose detector composed of porous
nickel-based metal oxide framework (Ni-MOF), where the electrical conductivity was enhanced by
addition of CNT. These electrodes exhibit a high glucose selectivity and this method is proposed as a
relevant alternative to detection through immune complexes immobilisation [23].
2.1.2. Imaging Methods Based on CNT
Various technologies based onCNT are available in the imaging field. For example, photoluminescent
imaging takes advantage of the fluorescence of excited SWCNT in the Near InfraRed-I (700–900 nm)
and NIR-II (1100–1400 nm) ranges, wavelengths at which tissues and water are almost transparent,
making possible to reach deeper penetration depths. Welsher et al. used this property to optically
track in real time the biodistribution of injected SCWNTs in mice deep tissues and vessels [24,25].
SWCNT fluorescence is emerging as a reliable optical imaging method for vessels observation [26,27]
(Figure 2) and was more recently used as an optical alternative to the expensive positron emission
tomography-computed tomography for brown fat detection [28].
 
Figure 2. In vivo mouse brain imaging with SWNT–IRDye800 in different Near InfraRed (NIR) sub
regions. (a) A C57Bl/6 mouse head with hair removed. (b–d), Fluorescence images of the same mouse
head in the NIR-I, NIR-II and NIR-IIa regions. In (d), the inferior cerebral vein, superior sagittal sinus
and transverse sinus are labelled 1, 2 and 3, respectively. Reprinted with permission [26].
The photoacoustic effect is another interesting way to use CNT NIR absorption. Photoacoustic
imaging measures the ultrasounds produced by tissues expansion around heat emitting CNT exposed
to NIR stimulation. De La Zerda et al. obtained improved contrast on targeted tumour cells thanks
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to SWCNT conjugated with Arg-Gly-Asp peptides as well as an enhanced sensitivity and detection
threshold, compare to pristine SWCNT [29,30].
Raman scattering is also an imaging option, thanks to the G band exhibited by SWCNT around
1580 cm−1. Liu et al. demonstrated the use of the combination of peak shifting for SWCNT depending
on the 13C/12C isotopic ratio with the labelling by different targeting ligands, leading to ﬁve-colour
multiplexed Raman imaging [31]. Furthermore one of the major drawback of Raman imaging,
the acquisition time, may have found a major improvement with the recent development of Raman
hyperspectral instrument with Bragg tuneable ﬁlter, thereby increasing impressively the scan speed
and scanned surface [32]. MWCNT usually exhibit a lower signal/noise ratio compared to SWCNT
and DWCNT and the sensitivity of this approach thus depends on the nature of the biological matrix.
The radioprobes presented by Hong et al. used for single-photon emission computed tomography
imaging (SPECT) and composed of metal halides encapsulated within CNT, illustrate another
application of CNT in bioimaging [33]. Furthermore, the proposed 1,3-dipolar cycloaddition of
CNT represents a promising substitute option to widespread CNT surface oxidation as it enables the
functionalisation without opening the closed ends and should thus prevent the release of radionuclides
and their accumulation in thyroid and stomach. This functionalisation method was also utilised to
conjugate oxidised MWCNT with gadolinium, which is an element commonly used as contrast agent
for magnetic resonance imaging (MRI). Gd-MWCNT exhibited enhanced MRI contrast compared to
actual commercial ones [34].
2.2. CNT Use for Tissue Engineering
Inﬂuence of CNT on living cells draws more and more attention as utilisation of CNT as base
material for biomedical applications is increasing. Lovat et al. shown that CNT represent a good
surface for cellular growth and have a promoting effect on neural signal transmission [35]. Moreover,
Mazzatenta et al., by investigating the coupling model between SWCNT and hippocampal cells,
have proved that SWCNT may directly stimulate brain circuit activity, highlighting SWCNT as a
promising material [36]. Béduer et al. obtained similar results. They demonstrated that neurons would
preferentially grow on DWCNT compared to SiO2 surface, due to a favourable surface texture and
better adsorption of culture medium proteins, allowing patterning of neurons networks as illustrated
in Figure 3. Cell differentiation was also enhanced when the growth took place on DWCNT [37].
Raw (non-functionalised) aligned MWCNT successfully sustained the growth and proliferation of
pancreatic cancer cells, exhibiting a new approach for the study of this kind of cancer [38].
 
Figure 3. Neuro2a cells culture on a SiO2/CNT micropatterned surface. (a) SEM images of neuro2a
cells cultured on patterned surfaces after 2 days of differentiation. Arrows point to neurites developed
on CNT patterns. The letter A indicates a speciﬁc cell body on a CNT feature and the letter B points
out a speciﬁc cell body outside of a CNT feature (on a SiO2 feature). (b) Optical ﬂuorescence image of
neural cells grown on CNT patterns after phalloidin staining. Note that neurites follow the CNT lines
turning at an angle of 90◦. Reprinted with permission [37].
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The ability of CNT to form 3D architecture described by Correa-Duarte et al. is equally interesting
for cell proliferation enhancement and tissue engineering. The proposed MWCNT network could be
shaped to ﬁt best natural tissue morphology but also remained stable in vivo [39]. Abarrategi et al.
developed CNT/chitosan meshes to support cell recolonization and observed their disassembly in vivo
through dispersion in newly grown tissue [40]. Different kinds of CNT-based scaffold supporting
cell colonisation were reported since [41]. The question of the potential release of CNT in case of
biodegradation and the possible related toxicity issues will be discussed later on.
2.3. CNT Use for Targeted Therapies
Efﬁcient drug administration is a real concern in the medical ﬁeld. Indeed, low selectivity and low
half-life time may lead to multiply the administrations, resulting in secondary effects and sometimes,
fatal issues. Due to their expected biocompatibility and suitable size, CNT are widely studied as
nanocarriers for drug and gene delivery as well as cancer treatment.
2.3.1. CNT as Carrier for Drugs and Gene Delivery
The use of CNT as nanocarriers has drawn more and more attention in last years since CNT
exhibit exceptional cell transfection capabilities. Liu et al. have shown that drugs such as doxorubicin
(DOX) can be loaded onto the surface of poly(ethylene glycol) (PEG) conjugated SWCNT thanks
to non-covalent bounds and can reach the tumorous tissue thanks to the enhanced permeability
and retention (EPR) effect. A pH - release dependency would also permit delivery close to the
tumour tissues [42,43]. Wells et al. relied on a mesoporous silica coating to load drugs on CNT [44].
In those examples, DOX was easily released in the acidic environment found in tumorous tissues
but stayed bound to CNT at neutral and alkaline pH, limiting toxicity within the healthy body
parts [42–44]. PEG branches also increased the hydrophilicity of SWCNT and protected the DOX
bound to the nanotubes, extending its stability and lifetime in blood circulation. Another anticancer
drug, 10-hydroxycamptothecin (HCPT) was successfully covalently linked to MWCNT and also
exhibited the enhanced efﬁciency of CNT-conjugated drugs, as well as the possibility to couple
imaging to this kind of treatment (theranostic approach) [45]. Recently, hydroxypropyl-β-cyclodextrin
(HP-β-CD)-modiﬁed SWCNT-COOH also exhibited a rather good formononetin entrapment and a
slow and sustained release [46] which might be useful for enhanced cancer treatment.
CNT have also the capacity to enter cells [47], independently of the functional groups they
may have on the surface [48], allowing intracellular drugs delivery but also genes and proteins
delivery. This is of particular interest for the development of gene silencing therapy, thanks to short
interfering RNA (siRNA) delivery inside cytoplasm. Bartholomeusz et al. successfully dispersed
SWCNT in siRNA solutions, without using any functionalisation of the nanotubes and demonstrated
90% of transfected cells within 6 h, associated with 70–80% of HIF-1 silencing and more importantly
without the disadvantage of viral vectors, such as inﬂammation or immune response [49]. Ladeira
et al. introduced siRNA in rather hard-to-transfect cells thanks to carboxyl-functionalised SWCNT
with an efﬁciency of 96% of silencing [50]. Sanz et al. used a combination of functionalisation both
outside (polyethyleneimine) and inside (chloroquine) for DNA plasmid delivery [51] In this work,
the chloroquine, a lysosomotropic compound, was released from the CNT only at the low pH inside
lysosomes, making possible the delivery of the DNA plasmid within the cytoplasm and ﬁnally to the
cell nucleus. Gene silencing represents a concrete alternative treatment for pathologies and particularly
for those localised in delicate zones such as the brain, since it has better efﬁciency than direct inhibitor
injection [52]. The cellular uptake pathway of MWCNT β-cyclodextrin nanoplatform with branched
poly(ethylenimine) (MWCNT-CD-PEI) loaded with cidofovir (Cid) was recently elucidated thanks
to rhodamine (Rhod) doping and imaging by Mazzaglia et al. [53]. MWCNT-CD-PEI-Rhod were
internalised through endocytosis and small drugs like Cid would escape lysosomes vesicles.
Kaboudin et al. demonstrated transfection of nucleic acid through another mechanism than
endocytosis in a recent work. MWCNT functionalised with pyridine and magnetic particles transported
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nucleic acids bound by π-π interactions through the cell membrane and released them in the cytoplasm.
A magnetic ﬁeld was then applied to remove the nanocarriers from the cell, thus limiting their
cytotoxicity [54]. Magnetically guided nanocarriers were also considered by Xu et al. through
the one-step preparation of magnetic MWCNT using a paramagnetic surfactant coating. DNA is
compacted thanks to electrostatic forces allowing the endocytosis transfection of the nanoplatform [55].
Salts shielding the interaction between the cargo and the CNT permitted the release of DNA inside
the cytoplasm.
Using another strategy, Kong et al. considered the use of NIR light irradiation to help the DNA
delivery. Laser stimulation of SWCNT coated by poly(ethyleneimine)-cholesterol (PEI-Chol) induced
membrane permeabilization due to SWCNT photothermal activity, promoting cellular uptake and
DNA release [56]. However, as remarked, further works are still needed to determine CNT pathways
and fate inside tissues depending on their formulation.
2.3.2. Anticancer Therapies Based on CNT
Taking advantage of CNT photothermal properties with NIR laser stimulation was considered as
an elegant way for directly treating cancer. Burke et al. showed that intra-tumoral injection of MWCNT
suspension, followed by short laser excitation resulted in tumour ablation in mice and enhanced
survival [57]. On the other hand, intravenous injection of SWCNT conjugated with anti-CTLA-4
described by Wang et al. triggered immune reaction and enhanced cytotoxic activity additionally to
the Photothermal Therapy (PTT), resulting in the destruction of the remaining nodules/metastasis [58].
The coupling of imaging methods with PTT was also proposed to promote treatment of primary
tumours and detection of connected lymph nodes in a single step as illustrated [59]. Recently,
MWCNT/gold nanostars hybrids have provided signiﬁcant improvement in terms of photothermal
conversion, making it possible to limit laser stimulation time during the therapy [60]. Furthermore,
the combination of molecules delivery and PTT described by Wang et al., also used by Wells et al.,
broadens the application range of this cancer therapy method [44,61]. CNT-assisted PTT is however
limited by laser penetration depth in tissues and still needs to prove its efﬁcacy for thicker samples.
Most of the works presented in this section have determined the toxicity of CNT on cells
during their utilisation but the fate and possible degradation of those objects were not thoroughly
examined. This concern, still controversial, could be the most important drawback of CNT application
in biomedicine when the nanotubes are not trapped within or at the surface of a device.
3. CNT-based Hydrogels for Biomedical Applications
Hydrogels are 3D polymeric cross-linked ediﬁces where water absorption is made possible thanks
to hydrophilic functional groups. Those materials can be classiﬁed in two groups depending of
the nature of the cross-linking interactions. In chemical hydrogel, obtained for instance by radical
polymerization or UV irradiation, the cross-linking is permanent and of covalent nature. Physical
cross-linking is about electrostatic interactions and thus induces a possible reversibility aspect [62].
Hydrogels are not the only polymers used in CNT-based nanocomposites synthesis. For instance,
Martinelli et al. developed cardiac tissue scaffolds composed of polydimethylsiloxane [63] and Mamidi
et al. evaluated the cytotoxicity of CNT in ultrahigh molecular weight polyethylene on ﬁbroblasts [64].
However, the following paragraphs will focus only on CNT-Hydrogel nanocomposites.
3.1. Biopolymer-Based Hydrogels
Hydrogels are widely used in the biomedical ﬁeld due to their biocompatibility and the low
inﬂammatory responses they induce [65]. Their porosity and hydrophilicity allow cargo molecules to
be loaded, for drug delivery or for biosensing purposes [66] and their mechanical properties can be
suitable for applications in tissue engineering [67]. The reversibility of physical hydrogels is also quite
interesting as it can be the source of phase transitions, exploitable for in situ injection [68]. Several
hydrogels can respond to different stimuli like temperature or pH variation [69], light exposure or
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electric ﬁeld application. They represent thereby promising materials for targeted and controlled drug
delivery, especially as, in some case, it can also be operated remotely.
Several polymers are suitable for hydrogel synthesis but natural polymers are more often selected
for biomedical application because most are biocompatible and renewable. Some synthetic polymer
also ﬁt biocompatibility criteria (nontoxic and inducing low inﬂammation). Those polymers or
monomers are often used combined with others, Table 1 gathers the main monomer/polymer families
used for the synthesis of hydrogels. It is the reticulation of those polymers which determines the
ﬁnal properties of the gel. However, in spite of their potential for the various applications cited in
the previous paragraph, the intrinsic properties of hydrogel matrices are limited. Their enhancement
was thus investigated through the use of additional polymers or the inclusion of nanoparticles such
as CNT.
Table 1. Bio-sourced polymers and synthetic monomers used for the synthesis of hydrogel matrices for
biomedical applications [62,66,70,71].
Bio-Sourced Polymers Synthetic Monomers
Agarose Acrylamide (AM)
Alginate Acrylic acid (AA)
Chitosan Ethylene glycol (EG)
Collagen Hydroxyethyl methacrylate (HEMA)
Dextran Lactic acid (LA)
Fibrin Methyl methacrylate (MMA)
Hyaluronic acid Vinyl alcohol (VA)
Pectin -
3.2. CNT-Based Hydrogels for Diagnostic
Most biosensors developed using CNT based-hydrogel focused on glucose detection, as it is
well documented. Several of them consist of electrodes allowing the monitoring of electron transfers
within the redox couple glucose oxidase (GOx)-glucose. Conductive Bacterial cellulose (BC)-CNT-GOx
ﬁlms were directly used as electrodes by Kim et al., offering a simple and biocompatible material
for cyclic voltammetry monitoring [72]. Comba et al. developed a very reliable glucose biosensor,
with long-term stability using a sandwich conﬁguration. In their work, the biosensor matrix was
composed of albumin (alb), GOx and carbon nanotubes-mucin composite (CNT-muc) crosslinked with
glutaraldehyde were inserted between two polycarbonate membranes [73]. Fatoni et al. used porosity
to entrap the enzyme using a chitosan-bovine serum albumin (Chi-BSA) cryogel where embedded
MWCNT enhanced electron transfer. The redox reaction was followed by amperometry [74].
The 3D architecture and mechanical properties of CNT-based hydrogels allow the design of
different types of sensing methods. The optical glucose sensor presented by Barone et al. was
based on a shift of photoluminescence (PL) emission of CNT embedded in poly(vinyl alcohol) (PVA)
hydrogel, induced by apo-glucose oxidase (apoGOx) and glucose interaction. ApoGOx attached
to PVA contributed to the cross-linking of the hydrogel and its interaction with glucose modiﬁed
PVA conformation and hydrostatic pressure, resulting in CNT lattice deformation and change of
the environment [75]. This works demonstrated the in vivo use of CNT PL with the perspective
of limiting CNT release and associated toxicity concerns. Two different teams recently developed
sensor-actuators reacting to glucose-GOx. In both works, hydrogel particles inserted in MWCNT
twist yarn provoked swelling/de-swelling in the presence of glucose. Lee et al. took advantage of the
exothermal character of the enzymatic reaction to activate the fast shrinkage of a thermally sensitive
hydrogel, the poly(N-isopropylacrylamide) [76] adsorbed on MWCNT yarn. For the other team it was
the binding of glucose with the boronic acid-conjugated with hyaluronic acid/cholesterol nanogel,
which changed molecular interactions and swell the MWCNT yarn [77]. In the latter report, the authors
observed a linear relationship between glucose concentration and the yarn’s rotation angle. A ﬂexible
and light strain sensor, suitable for human motion detection, was recently reported by Hosseini et al.
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Bacterial cellulose (BC)/(MWCNT) hydrogel was dried into a piezoresistive aerogel using supercritical
CO2 drying [78].
3.3. CNT-Based Hydrogels Use for Tissue Engineering
Maintaining the recolonization of cells in order to replace dead or harmed tissues requires
scaffolding materials that respect certain properties. They should be able to form cross-linked networks,
be mechanically resistant, biocompatible and should allow good cell adhesion. For such purposes,
hydrogels based on biopolymers are often preferred. Furthermore, the inclusion of nanoﬁllers such
as CNT in those matrices enhance the mechanical properties [79] but also improves the electrical
conductivity (when needed). For example, the regulation of the electroactive behaviour of cardiac
or nervous cells during the tissue regeneration process is very important. For instance, Yildirim
et al. demonstrated that the inclusion of 1 wt.% of SWCNT in an alginate scaffold was enough to
improve the tensile strength close to that displayed by natural tissues, as well as increasing cell
attachment and proliferation [80]. Mechanical and electrical properties of scaffolds can be tuned by
modifying the CNT concentration [81] and/or orientation inside the hydrogel [82]. Ahadian et al.
reported a tuneable gelatine methacyoyl (GelMA)/aligned MWCNT scaffold which enhanced the
differentiation of embryoid bodies into cardiac cells, meaning this could represent a suitable support for
any tissue regeneration based on stem cells therapy [82,83]. The enhancement of physical properties is
particularly promising for cardiac reinforcement application, where electrical conductivity is essential
but also for bone tissue regeneration. In that way, different works show that the CNT incorporation in
biopolymer-based hydrogels could support the growth of cardiomyocytes ﬁtting for cardiac tissue
engineering [84] or cardiac patches [85]. Furthermore, Zhang et al. have shown the promoting effect of
SWCNT on osteoblast proliferation in chitosan scaffold containing crystalline hydroxyapatite, compare
to pristine hydrogels, as well as enhanced tensile and compressive modulus [86]. The scaffolds
presented by Cancian et al., composed of non-covalently included CNT in thermosensitive chitosan
hydrogels, exhibited appropriate viscosity for local injection, a method which could replace invasive
surgeries like bone grafts [87]. Recently, Liu et al. described a promising method aiming to ﬁll in
the gap resulting of spinal cord injury (Figure 4). Nerve conduits composed of PEG functionalised
CNT/oligo (poly(ethylene glycol)fumarate) (OPF) nanocomposite were generated using injection
moulding technique. The described hydrogel demonstrates the enhancement of cell attachment and
proliferation, conﬁrming that the nerve conduits could help axon recovery [88].
Figure 4. (a) Schematic demonstration of the spinal cord in the human body. (b) Conductive nerve
conduits for spinal cord injury treatment. (c) Structure of the conductive OPF-CNTpega hydrogel.
Reproduced from [88] with permission from the Centre National de la Recherche Scientiﬁque (CNRS)
and The Royal Society of Chemistry.
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In the ﬁeld of cancer engineering, intensiﬁed cell proliferation linked to the presence of CNT can
also be exploited for patterning cells growth, as shown by cancer spheroid formation in the report by
Sheikholeslam et al. [89].
3.4. CNT-Based Hydrogels for Targeted Therapies
The use of CNT-based hydrogels for drug delivery is quite new but was investigated by many
authors, as reported in the extensive review of Cirillo et al. [71]. The porous structure of biocompatible
hydrogels combined with the mechanical and electrical properties improvement brought by CNT were
shown to increase drug molecules stability and allow for more sustained delivery, which is of a great
interest for efﬁcient therapies [90,91]. Furthermore, this kind of material permits the development of
other delivery methods, such as transdermal delivery patches.
3.4.1. CNT-Based Hydrogels Use for Drug Delivery
Several teams investigated the possibility of electro-responsive CNT-based hydrogels for drug
delivery. For instance, Spizzirri et al. synthesised microspheres through the polymerisation of
gelatine containing MWCNT with the help of sodium methacrylate and N,N′-ethylenebisacrylamide.
The drug, diclofenac sodium salt, was loaded by soaking of microspheres into a concentrated solution.
The authors shown that the application of a 9V tension on the beads induced a shrinkage and thus
increased the drug release [92]. This team also brought to light that the drug release behaviour
was different depending on the charge of the drug. Experiments carried out on acrylamide and
N,N′-ethylenebisacrylamide ﬁlm polymerised by UV stimulation containing covalently introduced
MWCNT, revealed that the release rate of anionic drug increased under 12V stimulation while cationic
drugs were retained and released faster without electrical stimulation [93]. This was explained by the
accumulation of negative charges on CNT when under 12V stimulation. Servant et al. considered the
use of implantable CNT-based hydrogels for remote electrically controlled delivery. They reported
methacrylic acid free-radical polymerisation in presence of pristine MWCNT to allow pulsatile drug
release. The application of electrical pulses stimulated the drug release; however, they shown that the
delivery rate turned back to normal quickly after the pulse end, offering more accuracy [94,95].
As for CNT-based drug carriers, pH-controlled drug delivery systems based on CNT/hydrogel
nanocomposites were also considered. Peng et al. reported a different swelling of MWCNT/chitosan
hydrogel depending of the pH of buffers mimicking two gastrointestinal environments, impacting the
release rate [96]. Ye et al. also shown that pH had an inﬂuence on wettability and swelling of vertically
aligned CNT covered by poly(methacrylic acid-co-ethylene glycol diacrylate) (P(MAA-co-EGDA)),
which could lead to controlled release [97].
Wei et al. designed a dual release carrier with CNT/polycaprolactone (PCL)-PEG-PCL
thermosensitive hydrogel, where DOX was loaded on CNT while Rhod was within the hydrogel.
The difference of drug loading is pointed out as the source of the observed release rate. Furthermore,
pH dependency was also noticed [98]. CNT based-hydrogels could also ﬁnd applications in cancer
therapy: Hindumathi et al. conﬁned CNT inside a PEG cocoon in order to load drugs such as curcumin,
allowing curcumin cellular uptake [99].
3.4.2. CNT-Based Hydrogels Use for Skin Delivery
As Kuche et al. explained in their review work, the major drawbacks of existing transdermal
delivery patches are the low drug release rate and the poor skin permeability [100]. CNT based
nanocomposites could bring an innovative solution to both problems thanks to their intrinsic properties.
As shown previously, this kind of hydrogel could improve drug stability through time and grant
more control on the release rate. Im et al. were able to make such a patch by the electrospinning of a
polyethylene oxide/pentaerythritol triacrylate/MWCNT hydrogel and they observed a correlation
between drug release and applied voltage [101]. Membranes developed by Bhunia et al., made of PVA
and carboxy-functionalised MWCNT [102], or by Giri et al., composed of 2-hydroxyethyl methacrylate
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grafted carboxymethyl guar gum and functionalised MWCNT [103], both exhibited encouraging
performances for diltiazem and diclofenac release, respectively.
The recent work of Guillet et al. opens a new route to solving both problems at once using
CNT-based hydrogels directly as an electrode for skin electroporation. The application of high voltage
electrical pulses through the skin was shown to temporarily create pores within the stratum corneum,
which large molecules like insulin, carried by electrophoretic forces, may use to cross this natural
barrier. The developed agarose/DWCNT hydrogel was use directly on mice skin as both drug
storage system and electrode and demonstrated preserved mechanical properties but most importantly
enhanced drug penetration into the skin, as shown in Figure 5 [104]. This work represents a promising
application of CNT-based hydrogels with a very clear improvement and practical use.
 
Figure 5. Visualization of skin electroporation. Representative pictures of mouse skin after
electropermeabilisation with CTRL-AGsummuri and DWCNT-AG (1 wt.% DWCNT) containing 4 kDa
FITC-dextran at 1 mm. Images (a,d) show CTRL-AG and DWCNT-AG without electrical stimulation
under identical conditions at the same intensity level (×0.57). Images in (b,e) are with electrical
stimulation: The anode is on the left-hand side and the cathode on the right-hand side (magniﬁcation
×0.57). (c,f) Magniﬁcations (×4) of the anode area of (b,e), respectively. The frame on the left side of
(c,f) pictures shows a numerical magniﬁcation ×400. Reprinted with permission [104].
Table 2 summaries the different application ﬁelds addressed in this review and the corresponding
reference of cited works. In addition to this academic work, it is important to note that a few patents
are also available. They all correspond to (potential) applications in the biomedical ﬁeld in which
CNT are included mainly to enhance the performances of existing medical devices and not for the
development of new speciﬁc “nano-related” applications [105–111]. Furthermore, there are only few
clinical trials involving CNT-based materials for biomedical applications and they mainly deal with
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biosensor for in vitro detection [112]. The main reason identiﬁed for this lack of practical application is
most probably the toxicity issue of CNT which will be discussed in the last section.
Table 2. Summary of the cited works sorted by application ﬁeld.
CNT CNT-Based Hydrogels
Biosensors [15–23] Diagnostic [72–78]
Imaging [24–34]
Cells guidance and tissue scaffolds [35–41] Cells guidance and tissue scaffolds [79–89]
Drugs and gene delivery [42–56] Drugs delivery [71,90–99]
Anticancer therapies [44,57–61] Skin delivery [100–104]
4. Potential Toxicity Issues Related to CNT
The toxicity of CNT is a complex subject to address as CNT actually gather a family of
nanoparticles, which properties and behaviour are related non-exhaustively to their structure, number
of walls, chirality, diameter and length [113]. However, several observations can be made from the
different studies which try to answer to that question. CNT may enter the organism through three
different pathways: injection, ingestion and inhalation. The interferences between those nanoparticles
and organs or cells exist and could be the source the varying severity and sometimes fatal issues of
disease development, as described in the review work of Madani et al. [114]. Effect of several CNT on
different targeted cells were also compared by Cui et al. Yet this team, as others, insists on the need of
more toxicity studies on the long term in order to get more perspective on this subject [115,116].
As described earlier in this work, CNT can transfect cells. Thanks to labelled MWCNT and
further imaging it was proved that once inside the body, they could cross barriers, reach blood
circulation and thus, spread within the organism [117,118]. CNT can either exit the body via urinary
excretion or accumulate in secondary organs, staying indeﬁnitely if the immune system fails to
eliminate them [116]. Their biopersistence was demonstrated by Czarny and co-workers up to
12 months, without decrease [119]. CNT biodistribution is linked to several parameters such as
functionalisation, dispersion and length. According to the review by Ali-Boucetta et al. on CNT
toxicokinetics, covalently functionalised CNT tend to be excreted through urine whereas pristine
and non-covalently functionalised CNT would accumulate in liver and spleen. CNT ability to
disperse seems also a key parameter to take into consideration in toxicity. Functionalisation with
small hydrophilic groups like PEG allows good and stable CNT dispersion. It is however important to
know that most functionalisation processes require a former puriﬁcation or activation by oxidation
and that most MWCNT (in particular but not only) are signiﬁcantly cut during the process, meaning
in the end that it is very difﬁcult to decorrelate the relative inﬂuence of length and functionalisation
on the toxicity. The formation of CNT bundles is usually an unwanted issue as bigger agglomerate
accumulate quickly, possibly leading to damages to neighbouring cells as they are easily detect by
the immune system but not always phagocytosed because the length of the particles mays prevent
macrophages from engulﬁng them properly [116,120]. Those observations are illustrated in Figure 6.
The parallel is often made between CNT and asbestos as both particles are non-biodegradable ﬁbres
that the immune system fails to deal with. However, there are important differences between the
two and the analogy is probably limited to the morphology and non-biodegradability as well as the
activation of inﬂammation mechanisms when able to get within cells [121].As evidenced by some
groups, CNT may however exhibit an anti-oxidant activity when they are outside the cells, by trapping
of reactive oxygen species [122]. Quarantine of CNT by ﬁbrosis could causes discomfort yet put an end
to the inﬂammation triggered by immune system overactivity. Otherwise, the prolonged inﬂammation
tends to degrade environment cells and lead to the development of cancer [123]. Puriﬁcation step of
CNT appear necessary, as the presence of metallic particles is source of oxidative stress and thus cells
damaging [124,125]. Furthermore, puriﬁcation method often results in CNT shortening.
Materials 2019, 12, 624 13 of 21
A study of Allen et al. on horseradish peroxidase (HRP) degradation effect on carboxylated
SWCNT suggested that polycyclic aromatic hydrocarbons (PAHs) may be found among the
degradation products [126]. Moreover, carboxylated SWCNT are signiﬁcantly more impacted by the
HRP than pristine SWCNT which is important to consider as carboxylation is a common consequence of
the puriﬁcation step(s) [7]. In this sense, pristine CNT are less prone to biodegradation by peroxidases
and thus more stable, while oxidized CNT biodegradation may lead to the release of toxic by-products
in case of (very likely) incomplete degradation.
The use of different kinds of CNT with different morphologies and purities, with different
biological models (cancer cell lines versus primary cells; in vitro versus in vivo; different animal
models) at different doses using different dispersion/exposure/characterisation protocols certainly
explains why the answer about the potential toxicity of CNT is still not available. The question of
suitable doses for toxicity assessment is also a delicate matter. The actual exposure to CNT in real
conditions is hard to quantify and concentrations used for testing the toxicity of CNT is generally far
from reality. Finally the use of the weight concentration to express the exposure dose, although very
practical to use, is rather irrelevant especially for comparison purposes and should be replaced by the
surface concentration which is much more relevant [127].
Figure 6. (a) The effect of CNT structure on phagocytosis by macrophages and clearing from tissues.
Whereas macrophages can engulf MWNTs with a low aspect ratio (ratio of length to width) before
their clearance by draining lymph vessels, MWNTs with a high aspect ratio cannot be cleared and
accumulate in tissues, where they promote carcinogenesis. (b) In addition to their dimensions, other
considerations relevant to the safety of CNT include increasing their solubility and preventing their
aggregation, to facilitate urinary excretion and thereby prevent tissue accumulation. Reprinted with
permission [123].
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In regard of those observations, the most cautious way to use CNT would be to prevent them
from entering freely the organism. As such, trapping of CNT inside hydrogels contributes to limit
the risk of direct interaction with CNT, promoting a safe-by-design development direction, while
improving hydrogel properties [128]. However, to ensure no CNT release, the biocompatible polymer
should be non-biodegradable and remain unaffected within the body.
5. Conclusions
CNT are promising materials in the biomedical ﬁeld. Once functionalised to ensure their
biocompatibility and conjugated with organic compounds or metallic nanoparticles, they can be
used as efﬁcient biocompatible biosensors or contrast agent for imaging but could also increase drugs
lifetime within the body and facilitate their direct delivery within cells. Their usefulness in cell growth
and recolonization is well illustrated, in particular for nervous cells. The use of CNT as additives inside
matrices, especially biocompatible hydrogels, is an encouraging alternative way of taking advantage of
their extraordinary properties while limiting the risk of direct exposure. It was shown that mechanical
and electrical properties of hydrogels could be greatly improved by embedding CNT and that those
nanocomposites could be used for biosensing, tissue engineering and drug delivery without the risk of
CNT release into cells. Furthermore, the 3D porous structure of hydrogel widens the possible range
of applications, offering more versatility, as shown by the recent development of injectable tissue
scaffolds or drug delivery patches.
If the investigation of CNT local cytotoxicity is often included in recent in vivo biomedical
application works and CNT generally shown not to be harmful for neighbouring cells, their fate
on long term within the body is unfortunately the subject of less attention. CNT situation after
they completed their intended task depends of many parameters including concentration, size and
functionalisation and if most of them are generally quickly excreted, the remaining part is to stay in
the body and accumulate leading to unknown long-term effects. However, as described in this work,
CNT conﬁnement inside hydrogels is a good way to limit their scattering inside the organism (as long
as the hydrogel itself is not biodegradable), representing a promising way of taking advantages of
those carbon nanoparticles for biomedical applications.
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